Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer.
Ding L, Jiang H, Li Q, Li Q, Zhang TT, Shang L, Xie B, Zhu Y, Ding K, Shi X, Zhu T, Zhu Y.
Ding L, et al. Among authors: jiang h.
J Exp Clin Cancer Res. 2024 Mar 25;43(1):90. doi: 10.1186/s13046-024-03016-9.
J Exp Clin Cancer Res. 2024.
PMID: 38523299
Free PMC article.